Cancer experts reported on developments of some promising radiosurgical techniques for treating lung and liver cancer using linear accelerator technology at the “Emerging Technologies Symposium” at the annual conference of the European Society for Therapeutic Radiology and Oncology (ESTRO) in London.
Dr. Marta Scorsetti, head of radiation oncology at the Humanitas Clinic in Milan, described an ongoing study involving 43 patients that is aimed at assessing the safety and feasibility of using RapidArc radiotherapy to deliver stereotactic body radiotherapy (SBRT) in the treatment of liver metastases. Results from the study, after seven months, were a local tumour control rate of nearly 94%.
